Electronic Prescribing and Medicines Administration (EPMA) System

The Medway Electronic Patient Record (EPR) has built-in prescribing and medicines administration for both inpatients and outpatients.

Designed by clinicians, and incorporating Microsoft Common User Interface guidance, Medway EPMA offers an intuitive prescribing experience, only requiring product-level detail from the prescribing clinician when it is clinically relevant.

Medway EPMA provides comprehensive clinical decision support. This includes information about drug-drug interactions and National Patient Safety Agency (NPSA) alerts. Checks against pathology results are an integral part of the prescribing and administration process. Full prescribing guidance can be accessed either through the First DataBank Multilex drugs knowledge base or locally-created content referenced within Medway.

The Medway EPR can also operate with prescribing software from third parties, including JAC and Ascribe.

Features:

• Reduced risk through the avoidance of illegible, incomplete or ambiguous prescriptions
• Improved formulary control
• Decision support at the point of prescribing (e.g. interactions, allergies)
• Support for pharmacist checking, authorisation and messaging to pharmacy systems for receipt of dispensing/stock control.
• Easy auditing of prescribing and administration practice.

Please note that Medway EPMA is under development and is being delivered in a number of phases.  Phase 1, TTOs and outpatient prescribing is going live early in 2012.

Medway EPMA Brochure

(996KB)